Theme 3: New Generation Antibody Therapies
|
Forum 3-1: Emerging Antibody Discovery Technologies |
|
|
Day 1: Afternoon, May 11, 2022 |
|
|
Chair |
Call for Chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:05 |
Speech Opportunity Available |
|
14:05-14:30 |
Speech Opportunity Available |
|
14:30-14:55 |
Speech Opportunity Available |
|
14:55-15:20 |
Speech Opportunity Available |
|
15:20-15:30 |
Coffee Break |
|
15:30-15:55 |
Speech Opportunity Available |
|
15:55-16:20 |
Speech Opportunity Available |
|
16:20-16:45 |
Speech Opportunity Available |
|
16:45-17:10 |
Speech Opportunity Available |
|
Forum 3-2: Antibody-Based Diagnostic Biomarkers |
|
|
Day 1: Afternoon, May 11, 2022 |
|
|
Chair |
Dr. Sawsan Madhi, Director General of FOCP, and Head of Pink Caravan's Medical and Awareness Committee, United Arab Emirates |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:05 |
Speech Opportunity Available |
|
14:05-14:30 |
Speech Opportunity Available |
|
14:30-14:55 |
Speech Opportunity Available |
|
14:55-15:20 |
Title: Friends of Cancer Patients Dr. Sawsan Madhi, Director General of FOCP, and Head of Pink Caravan's Medical and Awareness Committee, United Arab Emirates |
|
15:20-15:30 |
Coffee Break |
|
15:30-15:55 |
Speech Opportunity Available |
|
15:55-16:20 |
Speech Opportunity Available |
|
16:20-16:45 |
Speech Opportunity Available |
|
16:45-17:10 |
Speech Opportunity Available |
|
Forum 3-3: Antibody Drug Conjugates (ADCs) |
|
|
Day 1: Afternoon, May 11, 2022 |
|
|
Chair |
Call for Chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:05 |
Speech Opportunity Available |
|
14:05-14:30 |
Speech Opportunity Available |
|
14:30-14:55 |
Speech Opportunity Available |
|
14:55-15:20 |
Speech Opportunity Available |
|
15:20-15:30 |
Coffee Break |
|
15:30-15:55 |
Speech Opportunity Available |
|
15:55-16:20 |
Speech Opportunity Available |
|
16:20-16:45 |
Speech Opportunity Available |
|
16:45-17:10 |
Speech Opportunity Available |
|
Forum 3-4: Small Molecule-Conjugated Biotherapy |
|
|
Day 2: Morning, May 12, 2022 |
|
|
Chair |
Call for Chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Speech Opportunity Available |
|
09:25-09:50 |
Speech Opportunity Available |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
|
10:30-10:55 |
Speech Opportunity Available |
|
10:55-11:20 |
Speech Opportunity Available |
|
11:20-11:45 |
Speech Opportunity Available |
|
11:45-12:10 |
Speech Opportunity Available |
|
Forum 3-5: Bispecific and Multispecific Antibodies |
|
|
Day 2: Morning, May 12, 2022 |
|
|
Chair |
Call for Chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Speech Opportunity Available |
|
09:25-09:50 |
Speech Opportunity Available |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
|
10:30-10:55 |
Speech Opportunity Available |
|
10:55-11:20 |
Speech Opportunity Available |
|
11:20-11:45 |
Speech Opportunity Available |
|
11:45-12:10 |
Speech Opportunity Available |
|
Forum 3-6: FC Engineered Antibodies |
|
|
Day 2: Morning, May 12, 2022 |
|
|
Chair |
Call for Chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Speech Opportunity Available |
|
09:25-09:50 |
Speech Opportunity Available |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
|
10:30-10:55 |
Speech Opportunity Available |
|
10:55-11:20 |
Speech Opportunity Available |
|
11:20-11:45 |
Speech Opportunity Available |
|
11:45-12:10 |
Speech Opportunity Available |
|
Forum 3-7: Biosimilar Antibodies |
|
|
Day 2: Afternoon, May 12, 2022 |
|
|
Chair |
Call for Chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:05 |
Speech Opportunity Available |
|
14:05-14:30 |
Speech Opportunity Available |
|
14:30-14:55 |
Speech Opportunity Available |
|
14:55-15:20 |
Speech Opportunity Available |
|
15:20-15:30 |
Coffee Break |
|
15:30-15:55 |
Speech Opportunity Available |
|
15:55-16:20 |
Speech Opportunity Available |
|
16:20-16:45 |
Speech Opportunity Available |
|
16:45-17:10 |
Speech Opportunity Available |
|
Forum 3-8: Antibody Fragments and Antibody-like Proteins |
|
|
Day 2: Afternoon, May 12, 2022 |
|
|
Chair |
Call for Chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:05 |
Speech Opportunity Available |
|
14:05-14:30 |
Speech Opportunity Available |
|
14:30-14:55 |
Speech Opportunity Available |
|
14:55-15:20 |
Speech Opportunity Available |
|
15:20-15:30 |
Coffee Break |
|
15:30-15:55 |
Speech Opportunity Available |
|
15:55-16:20 |
Speech Opportunity Available |
|
16:20-16:45 |
Speech Opportunity Available |
|
16:45-17:10 |
Speech Opportunity Available |
|
Forum 3-9: Synthetic Antibody Mimics |
|
|
Day 3: Morning, May 13, 2022 |
|
|
Chair |
Call for Chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Speech Opportunity Available |
|
09:25-09:50 |
Speech Opportunity Available |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
|
10:30-10:55 |
Speech Opportunity Available |
|
10:55-11:20 |
Speech Opportunity Available |
|
11:20-11:45 |
Speech Opportunity Available |
|
11:45-12:10 |
Speech Opportunity Available |
|
Forum 3-10: Antibody Engineering and Bioanalysis |
|
|
Day 3: Afternoon, May 13, 2022 |
|
|
Chair |
Call for Chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:05 |
Speech Opportunity Available |
|
14:05-14:30 |
Speech Opportunity Available |
|
14:30-14:55 |
Speech Opportunity Available |
|
14:55-15:20 |
Speech Opportunity Available |
|
15:20-15:30 |
Coffee Break |
|
15:30-15:55 |
Speech Opportunity Available |
|
15:55-16:20 |
Speech Opportunity Available |
|
16:20-16:45 |
Speech Opportunity Available |
|
16:45-17:10 |
Speech Opportunity Available |
© 2003-2022 All rights reserved by BIT Group Global Ltd. |